Product
Dihydroartemisinin-piperaquine
Aliases
Dihydroartemisinin-piperaquine (DP), Duo-Cotecxin
5 clinical trials
5 indications
Indication
MalariaIndication
ChemoprophylaxisIndication
Under-five ChildrenIndication
HIV/AIDSIndication
Pregnancy RelatedClinical trial
Enhancing Immunity to Malaria in Young Children With Effective ChemopreventionStatus: Active (not recruiting), Estimated PCD: 2026-08-31
Clinical trial
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in UgandaStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Mass Drug Administration With Dihydroartemisinin-piperaquine and Primaquine to Reduce Malaria in a Moderate-low Transmission Setting in Senegal: A Cluster Randomized Controlled TrialStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
Effectiveness of Dihydroartemisinin-piperaquine as Seasonal Malaria Chemoprophylaxis in Extended High Transmission Settings of Tanzania: an Open Cluster Randomized Clinical Trial.Status: Completed, Estimated PCD: 2021-06-30
Clinical trial
Evaluation of the Safety and Efficacy of Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment of Malaria in HIV-infected Pregnant WomenStatus: Completed, Estimated PCD: 2022-07-19